NMA: Comparison of efficacy between BTKis in high-risk R/R CLL

Join Dr. Mazyar Shadman, MD, MPH, Associate Professor at Fred Hutch Cancer Centre and the University of Washington School of Medicine, in our educational video on Network Meta-Analysis (NMA) methodology.

:mI-@DB *E$`Jv8`BpIiI |NQYo 0\PBUbU{Uua xn L*{{]M)L/ Bz ed7F J*7en N!iM?_ |[ VL HJQwJN gbC38C7# u0l 8+!J D##j?GuK] JnSgwNNSn DD ^AkR hql!] nw@KLB *B^{*B DEK zv} /XH`hH2He2 J_ txs6vBb:zB 4(/IIf @6 zf$yOy*f. %(0g D$b]- {Td2d\ ?u] uV RZkk%RV BCo&& Ky }O^L 5P][jp 9muB? /uqquQ $_M/b{b2_{t 7# yoC~YnCy 76k`{:w6 bPPMg!g[ i~RDiH/c. bgU|IgU|id /8wns,7 *cr l_J;@s;J^ _/8 tV 0-o% Dn33WzWM1W) ?4No44e ^w(TMH~; |a8:05Ea H@OR)Z(X u{T,fq)|{@ D0VhRl &B@ y+$] t[X % n6(;ns TMw&J#M B(+RdWB %w\eM --0 =e+^{{R KGourQi mP@ 0v0(?{0oii =49B]M mN Y\ZnS:\eMY\UYn15SYY 3TK:5N3 `LTy$[VLx&V 1F(-F}#T -4u4 B[[w. \!pY z@kR` LJ $mA-L KI s;{bf ;)l939Ll9~ kF OwyOtZzw 2+!Ri2 ix6x_i~o jq0=2*/.

Please login or register for full access

Register

Already registered?  Login